These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 16216394

  • 1. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
    Yoshida S, Tanaka T, Kita Y, Kuwayama S, Kanamaru N, Muraki Y, Hashimoto S, Inoue Y, Sakatani M, Kobayashi E, Kaneda Y, Okada M.
    Vaccine; 2006 Feb 20; 24(8):1191-204. PubMed ID: 16216394
    [Abstract] [Full Text] [Related]

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 20; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
    Tuberculosis (Edinb); 2009 Jan 20; 89(1):54-61. PubMed ID: 19056317
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Fukamizu R, Tsunai Y, Inoue R, Nakatani H, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Sakatani M.
    Vaccine; 2007 Apr 20; 25(16):2990-3. PubMed ID: 17280753
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM, Bai YL, Shi CH, Gao H, Xue Y, Jiang H, Xu ZK.
    APMIS; 2008 Dec 20; 116(12):1071-81. PubMed ID: 19133010
    [Abstract] [Full Text] [Related]

  • 6. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
    Kita Y, Tanaka T, Yoshida S, Ohara N, Kaneda Y, Kuwayama S, Muraki Y, Kanamaru N, Hashimoto S, Takai H, Okada C, Fukunaga Y, Sakaguchi Y, Furukawa I, Yamada K, Inoue Y, Takemoto Y, Naito M, Yamada T, Matsumoto M, McMurray DN, Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Skeiky Y, Reed S, Sakatani M, Okada M.
    Vaccine; 2005 Mar 18; 23(17-18):2132-5. PubMed ID: 15755583
    [Abstract] [Full Text] [Related]

  • 7. Novel prophylactic and therapeutic vaccine against tuberculosis.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Inoue Y, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Vaccine; 2009 May 26; 27(25-26):3267-70. PubMed ID: 19200841
    [Abstract] [Full Text] [Related]

  • 8. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
    Okada M, Kita Y.
    Kekkaku; 2010 Jun 26; 85(6):531-8. PubMed ID: 20662249
    [Abstract] [Full Text] [Related]

  • 9. Cell-mediated immune responses and protective efficacy against infection with Mycobacterium tuberculosis induced by Hsp65 and hIL-2 fusion protein in mice.
    Shi C, Yuan S, Zhang H, Zhang T, Wang L, Xu Z.
    Scand J Immunol; 2009 Feb 26; 69(2):140-9. PubMed ID: 19144078
    [Abstract] [Full Text] [Related]

  • 10. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis.
    Lima KM, Santos SA, Lima VM, Coelho-Castelo AA, Rodrigues JM, Silva CL.
    Gene Ther; 2003 Apr 26; 10(8):678-85. PubMed ID: 12692596
    [Abstract] [Full Text] [Related]

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 26; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 12. The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.
    Okada M, Kita Y, Nakajima T, Hashimoto S, Nakatani H, Nishimatsu S, Nishida Y, Kanamaru N, Kaneda Y, Takamori Y, McMurray D, Tan EV, Cang ML, Saunderson P, Dela Cruz EC.
    Hum Vaccin Immunother; 2013 Mar 26; 9(3):515-25. PubMed ID: 23249543
    [Abstract] [Full Text] [Related]

  • 13. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM, Ryan AA, Triccas JA, Britton WJ.
    Infect Immun; 2006 Jan 26; 74(1):557-65. PubMed ID: 16369012
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
    Yuan W, Dong N, Zhang L, Liu J, Lin S, Xiang Z, Qiao H, Tong W, Qin C.
    Vaccine; 2012 Mar 23; 30(14):2490-7. PubMed ID: 21704108
    [Abstract] [Full Text] [Related]

  • 15. Effect of hsp65 DNA vaccination carrying immunostimulatory DNA sequences (CpG motifs) against Mycobacterium leprae multiplication in mice.
    Nomaguchi H, Mukai T, Takeshita F, Matsuoka M, Maeda Y, Aye TM, Jahan N, Yogi Y, Endo M, Sato Y.
    Int J Lepr Other Mycobact Dis; 2002 Sep 23; 70(3):182-90. PubMed ID: 12483966
    [Abstract] [Full Text] [Related]

  • 16. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
    Wang QM, Kang L, Wang XH.
    Microbiol Immunol; 2009 Jul 23; 53(7):384-90. PubMed ID: 19563397
    [Abstract] [Full Text] [Related]

  • 17. [The development of novel vaccines against tuberculosis].
    Okada M.
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct 23; 31(5):356-68. PubMed ID: 18974619
    [Abstract] [Full Text] [Related]

  • 18. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H, Li K, Yu S, Xiong S.
    Microbiol Immunol; 2009 Oct 23; 53(10):541-9. PubMed ID: 19780967
    [Abstract] [Full Text] [Related]

  • 19. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L, Cassone A.
    Cell Microbiol; 2007 Jun 23; 9(6):1455-65. PubMed ID: 17250590
    [Abstract] [Full Text] [Related]

  • 20. Vaccine adjuvant: it makes the difference.
    Lima KM, dos Santos SA, Rodrigues JM, Silva CL.
    Vaccine; 2004 Jun 23; 22(19):2374-9. PubMed ID: 15193397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.